| Literature DB >> 30768268 |
Christopher R M Asquith, Benedict-Tilman Berger1,2, Jing Wan, James M Bennett3, Stephen J Capuzzi, Daniel J Crona, David H Drewry, Michael P East, Jonathan M Elkins3,4, Oleg Fedorov3, Paulo H Godoi4, Debra M Hunter, Stefan Knapp1,2, Susanne Müller1, Chad D Torrice, Carrow I Wells, H Shelton Earp, Timothy M Willson, William J Zuercher.
Abstract
We describe SGC-GAK-1 (11), a potent, selective, and cell-active inhibitor of cyclin G-associated kinase (GAK), together with a structurally related negative control SGC-GAK-1N (14). 11 was highly selective in an in vitro kinome-wide screen, but cellular engagement assays defined RIPK2 as a collateral target. We identified 18 as a potent RIPK2 inhibitor lacking GAK activity. Together, this chemical probe set can be used to interrogate GAK cellular biology.Entities:
Mesh:
Substances:
Year: 2019 PMID: 30768268 PMCID: PMC6567991 DOI: 10.1021/acs.jmedchem.8b01213
Source DB: PubMed Journal: J Med Chem ISSN: 0022-2623 Impact factor: 7.446